54 results
Page 2 of 3
POS AM
etqa1xcg1jiqj8 dag0
1 May 23
Prospectus update (post-effective amendment)
5:19pm
6-K/A
EX-99.1
ghe94hz 11rrtst
1 May 23
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
6-K
EX-99.1
ylpsg2q
16 Dec 22
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8:06am
POS AM
bjdwhyq0zk1
14 Dec 22
Prospectus update (post-effective amendment)
8:04am
6-K
EX-99.1
fp8r0luduibj6
30 Nov 22
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
6:15am
6-K
EX-99.1
dwd7zu8uc55g0q9mi9o
10 Nov 22
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
4:04pm
424B3
ce8ct8r
1 Jul 22
Prospectus supplement
4:10pm
F-1/A
wbvkcw0fg
28 Jun 22
Registration statement (foreign) (amended)
4:02pm
F-1/A
qgbvedrd
21 Jun 22
Registration statement (foreign) (amended)
5:07pm
F-1/A
ag3u5enkj 6h7
10 Jun 22
Registration statement (foreign) (amended)
4:02pm
F-1
90ou4122wjqg
27 May 22
Registration statement (foreign)
4:26pm
6-K
EX-99.1
57s1luq 9s
19 May 22
Current report (foreign)
6:27am
425
qc03s or9quk
4 May 22
Business combination disclosure
4:03pm
425
28v 9stzq7t1t
12 Apr 22
Business combination disclosure
4:15pm
424B3
3lay6xe
11 Apr 22
Prospectus supplement
6:03am
F-4/A
jor uyublmeexnh1g81
30 Mar 22
Registration of securities (foreign) (amended)
5:10pm
F-4/A
fj5 d3icf55n33inj22
4 Mar 22
Registration of securities (foreign) (amended)
4:44pm
F-4/A
079kwbh17ree
18 Feb 22
Registration of securities (foreign) (amended)
5:00pm
F-4/A
z5yadqe3 bf
10 Feb 22
Registration of securities (foreign) (amended)
4:49pm